Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-23-028595

President & CEO sold 12,500 shares at $32.99 ($412,375)

  • President & CEO acquired 12,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Blum Robert I · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-30 Exercise or conversion : show line 1 in the form 10b5-1 +12,500 $6.67 $83,375 453,917 D
2023-11-30 Sale : show line 2 in the form 10b5-1 −12,500 $32.99 $412,375 441,417 D
Open-market sales · 12,500 sh · avg $32.99 · $412,375

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-30 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −12,500 180,994 D
Loading xslF345X05/form4.xml…